Archive for January, 2009

Internal Medicine News - Adjunctive gabapentin may help in postherpetic neuralgia

Sunday, January 11th, 2009

NEW YORK — The combination of gabapentin with an antiviral and analgesics was more effective than were those drugs without gabapentin for reducing pain in patients with herpes zoster, suggesting that it may prevent postherpetic neuralgia in these patients, said Dr. Stephen Tyring, who presented as-yet-unpublished findings at the American Academy of Dermatology’s Academy 2007 meeting.
Dr. Tyring, professor of dermatology, microbiology/molecular …

Chain Drug Review - Ivax unveils Gabapentin tablets

Saturday, January 10th, 2009

MIAMI — Ivax Corp. is marketing generic Neurontin (gabapentin) in 100-, 300- and 400-mg tablets.
The drug, indicated for the treatment of partial seizures, received approval from the Food and Drug Administration earlier this year as the first generic gabapentin on the market.
Besides having 180-day exclusivity for the tablets in those three strengths, Ivax has tentative approval from the FDA for a capsule version in those dosages and plans to begin selling the capsules upo…

M2 Presswire - Depomed Begins Dosing Patients in Phase 2 Trial For Gabapentin GR to Treat Menopausal Hot Flashes.

Sunday, January 4th, 2009

M2 PRESSWIRE-14 June 2007-ExplorationInvestor: Depomed Begins Dosing Patients in Phase 2 Trial For Gabapentin GR to Treat Menopausal Hot Flashes(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:14062007 Exploration Investor strives to provide…